The plasticity of human Treg and Th17 cells and its role in autoimmunity.

CD4(+) T helper cells are a central element of the adaptive immune system. They protect the organism against a wide range of pathogens and are able to initiate and control many immune reactions in combination with other cells of the adaptive and the innate immune system. Starting from a naive cell, CD4(+) T cells can differentiate into various effector cell populations with specialized function. This subset specific differentiation depends on numerous signals and the strength of stimulation. However, recent data have shown that differentiated CD4(+) T cell subpopulations display a high grade of plasticity and that their initial differentiation is not an endpoint of T cell development. In particular, FoxP3(+) regulatory T cells (Treg) and Th17 effector T cells demonstrate a high grade of plasticity, which allow a functional adaptation to various physiological situations during an immune response. However, the plasticity of Treg and Th17 cells might also be a critical factor for autoimmune disease. Here we discuss the recent developments in CD4(+) T cell plasticity with a focus on Treg and Th17 cells and its role in human autoimmune disease, in particular multiple sclerosis (MS).

[1]  C. Baecher-Allan,et al.  IL-17-producing human peripheral regulatory T cells retain suppressive function. , 2009, Blood.

[2]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[3]  D. Jarrossay,et al.  Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.

[4]  Hiromu Ito,et al.  Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model , 2007, The Journal of experimental medicine.

[5]  S. Mazmanian,et al.  Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.

[6]  M. Huber,et al.  IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype , 2008, Proceedings of the National Academy of Sciences.

[7]  M. Pender,et al.  Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. , 2008, Journal of autoimmunity.

[8]  G. Eberl,et al.  DC activated via dectin-1 convert Treg into IL-17 producers , 2008, European journal of immunology.

[9]  F. Luft,et al.  Mononuclear Phagocyte System Depletion Blocks Interstitial Tonicity-Responsive Enhancer Binding Protein/Vascular Endothelial Growth Factor C Expression and Induces Salt-Sensitive Hypertension in Rats , 2010, Hypertension.

[10]  Y. Belkaid,et al.  Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. , 2009, Immunity.

[11]  V. Kuchroo,et al.  Induction and effector functions of TH17 cells , 2008, Nature.

[12]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[13]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[14]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[15]  Q. Wang,et al.  Elevated Levels of CD4+CD25+FoxP3+ T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction , 2013, PloS one.

[16]  N. Tubridy,et al.  CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 , 2009, The Journal of Immunology.

[17]  W. Strober,et al.  Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β , 2007, The Journal of Immunology.

[18]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[19]  D. Kasper,et al.  A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease , 2010, Mucosal Immunology.

[20]  D. Munn,et al.  Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. , 2009, Blood.

[21]  Yong‐jun Liu,et al.  Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. , 2008, Immunity.

[22]  E. Tolosa,et al.  Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. , 2009, Brain : a journal of neurology.

[23]  C. Baecher-Allan,et al.  Human regulatory T cells and their role in autoimmune disease , 2006, Immunological reviews.

[24]  K. Berer,et al.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.

[25]  Yuka Kanno,et al.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.

[26]  L. Cosmi,et al.  Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells , 2012, European journal of immunology.

[27]  B. Becher,et al.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.

[28]  C. Fathman,et al.  Cd4+Cd25+ regulatory T cells and their therapeutic potential. , 2006, Annual review of medicine.

[29]  T. Solstad,et al.  CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. , 2011, Blood.

[30]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[31]  D. Hafler,et al.  Regulatory T cells in the central nervous system , 2012, Immunological reviews.

[32]  H. Weiner,et al.  Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.

[33]  S. Zheng,et al.  Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. , 2008, Trends in immunology.

[34]  M. Veldhoen,et al.  Fate mapping of interleukin 17-producing T cells in inflammatory responses , 2011, Nature Immunology.

[35]  J. Bach Regulatory lymphocytes: Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.

[36]  Clare Baecher-Allan,et al.  MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1 , 2006, The Journal of Immunology.

[37]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[38]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[39]  D. Fox,et al.  Th17 cells in human disease , 2008, Immunological reviews.

[40]  I. Türbachova,et al.  DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells , 2007, European journal of immunology.

[41]  K. Odunsi,et al.  Interleukin 2-mediated Conversion of Ovarian Cancer-associated CD4+ Regulatory T Cells Into Proinflammatory Interleukin 17-producing Helper T Cells , 2009, Journal of immunotherapy.

[42]  A. Regev,et al.  Induction of pathogenic Th17 cells by inducible salt sensing kinase SGK1 , 2013, Nature.

[43]  R. Geffers,et al.  Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. , 2006, Blood.

[44]  Yoichiro Iwakura,et al.  Review Functional Specialization of Interleukin-17 Family Members , 2022 .

[45]  Richard Bonneau,et al.  A Validated Regulatory Network for Th17 Cell Specification , 2012, Cell.

[46]  K. Scharffetter-Kochanek,et al.  Reduced CD18 Levels Drive Regulatory T Cell Conversion into Th17 Cells in the CD18hypo PL/J Mouse Model of Psoriasis , 2013, The Journal of Immunology.

[47]  A. Abbas,et al.  The life of regulatory T cells , 2013, Annals of the New York Academy of Sciences.

[48]  A. Rudensky,et al.  Foxp3 in control of the regulatory T cell lineage , 2007, Nature Immunology.

[49]  R. Andreesen,et al.  Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. , 2006, Blood.

[50]  Danila Valmori,et al.  Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt , 2009, Proceedings of the National Academy of Sciences.

[51]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[52]  S. Dasgupta,et al.  Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression , 2010, The Journal of Immunology.

[53]  P. Krammer,et al.  Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1 , 2007, The Journal of Immunology.

[54]  K. Alitalo,et al.  Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism , 2009, Nature Medicine.

[55]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[56]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[57]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[58]  H. von Boehmer,et al.  In Vivo Instruction of Suppressor Commitment in Naive T Cells , 2004, The Journal of experimental medicine.

[59]  A. Rudensky,et al.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Jay K Kolls,et al.  The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .

[61]  V. Boussiotis,et al.  Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells , 2012, PloS one.

[62]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[63]  D. Hoyt,et al.  Hypertonic saline enhances cellular immune function. , 1994, Circulatory shock.

[64]  Margaret A. Pericak-Vance,et al.  The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.

[65]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[66]  J. O’Shea,et al.  Helper T‐cell identity and evolution of differential transcriptomes and epigenomes , 2013, Immunological reviews.

[67]  A. Hamann,et al.  Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets. , 2005, Current topics in microbiology and immunology.

[68]  Sean M. Kearney,et al.  Microbial Reprogramming Inhibits Western Diet-Associated Obesity , 2013, PloS one.

[69]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[70]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[71]  J. Casanova,et al.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis , 2012, Current opinion in allergy and clinical immunology.

[72]  Irma Joosten,et al.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. , 2008, Blood.

[73]  M. Kleinewietfeld,et al.  CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. , 2009, Blood.

[74]  Dan R. Littman,et al.  Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.

[75]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[76]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[77]  G. Berry,et al.  Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.

[78]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[79]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[80]  F. Sallusto,et al.  Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.

[81]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[82]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[83]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[84]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[85]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[86]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[87]  S. Ziegler,et al.  Isoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP31 , 2008, The Journal of Immunology.

[88]  David E. Anderson,et al.  IL-21 and TGF-β are required for differentiation of human TH17 cells , 2008, Nature.

[89]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[90]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[91]  A. Hoischen,et al.  STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.

[92]  A. Rudensky,et al.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 , 2007, Nature Immunology.

[93]  S. Ho,et al.  NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[95]  S. Sakaguchi,et al.  Development and maintenance of regulatory T cells. , 2013, Immunity.

[96]  D. Harrison,et al.  Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. , 2013, The Journal of clinical investigation.

[97]  L. Cosmi,et al.  Defining the human T helper 17 cell phenotype. , 2012, Trends in immunology.

[98]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[99]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[100]  Chen Dong,et al.  TH17 cells in development: an updated view of their molecular identity and genetic programming , 2008, Nature Reviews Immunology.

[101]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[102]  J. Zepp,et al.  IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. , 2011, Trends in immunology.

[103]  M. Dallman,et al.  Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease , 2004, The Lancet.

[104]  Sergio E. Baranzini,et al.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.

[105]  C. Baecher-Allan,et al.  CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis , 2011, The Journal of Immunology.

[106]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[107]  J. O’Shea,et al.  Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. , 2013, The Journal of allergy and clinical immunology.

[108]  Hilde Cheroutre,et al.  Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.

[109]  D. Hafler,et al.  Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis , 2011, The Journal of Immunology.

[110]  M. S. Longhi,et al.  The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. , 2013, Journal of autoimmunity.

[111]  Rodrigo Liberal,et al.  Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. , 2012, Gastroenterology.

[112]  A. Hamann,et al.  Homing to suppress: address codes for Treg migration. , 2005, Trends in immunology.

[113]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[114]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[115]  A. Bar-Or,et al.  TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function , 2011, The Journal of Immunology.

[116]  M. Kleinewietfeld,et al.  CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. , 2005, Blood.

[117]  Chen Dong,et al.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. , 2008, Immunity.

[118]  Y. Li,et al.  Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis , 2011, Journal of Neuroimmunology.

[119]  V. Kuchroo,et al.  Th17: the third member of the effector T cell trilogy. , 2007, Current opinion in immunology.

[120]  S. Rutz,et al.  Regulation of epithelial immunity by IL-17 family cytokines. , 2012, Trends in immunology.

[121]  V. Kuchroo,et al.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.

[122]  P. Kivisäkk,et al.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.

[123]  Rapid In Vivo Conversion of Effector T Cells into Th2 Cells during Helminth Infection , 2012, The Journal of Immunology.

[124]  Jonathan H. Esensten,et al.  Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes , 2011, The Journal of Immunology.

[125]  B. Engelhardt,et al.  C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.

[126]  S. Zelenay,et al.  Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions , 2009, European journal of immunology.

[127]  N. Yosef,et al.  Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells , 2013, Nature.

[128]  P. Krammer,et al.  Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis , 2005, European journal of immunology.

[129]  Chen Dong,et al.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.

[130]  Jonathan S. Paw,et al.  Response to self antigen imprints regulatory memory in tissues , 2011, Nature.

[131]  Gary D. Stormo,et al.  The AP-1 transcription factor Batf controls TH17 differentiation , 2009, Nature.

[132]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[133]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[134]  Eva Tolosa,et al.  Phenotypical Characterization of Human Th17 Cells Unambiguously Identified by Surface IL-17A Expression1 , 2009, The Journal of Immunology.

[135]  M. Battaglia,et al.  Erratum: Interleukin-10- secreting type 1 regulatory T cells in rodents and humans (Immunological Reviews (2006) 212, (28-50)) , 2006 .

[136]  D. Littman,et al.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans , 2009, Proceedings of the National Academy of Sciences.

[137]  J. Bluestone,et al.  Plasticity of CD4(+) FoxP3(+) T cells. , 2009, Current opinion in immunology.

[138]  M. Kleinewietfeld,et al.  Hydrolysis of extracellular ATP by CD39+ Treg cells: context matters! , 2008 .

[139]  R. Andreesen,et al.  Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation , 2009, European journal of immunology.

[140]  L. Cosmi,et al.  The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. , 2008, International immunology.

[141]  L. Harrington,et al.  Expanding the effector CD4 T-cell repertoire: the Th17 lineage. , 2006, Current opinion in immunology.

[142]  A. Fischer,et al.  Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.

[143]  C. Elson,et al.  Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. , 2011, Gastroenterology.

[144]  P. van Erp,et al.  Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. , 2011, The Journal of investigative dermatology.

[145]  F. Safavi,et al.  The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.

[146]  A. Tsun,et al.  Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation , 2011, Protein & Cell.

[147]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[148]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[149]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[150]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.